Evaluation of In vivo Bioactivity of a Mutated Streptokinase
<br /><p> </p><h2>Background: Immunogenicity of Streptokinase, as a thrombolytic drug, has limited its clinical use. Elimination of the amino acid residues that are responsible for immunogenicity while don’t affect the bioactivity of streptokinase is worthy. Recently, we modi...
| Autors principals: | , , , , , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
Shahid Beheshti University of Medical Sciences
2017-04-01
|
| Col·lecció: | Novelty in Biomedicine |
| Matèries: | |
| Accés en línia: | http://journals.sbmu.ac.ir/nbm/article/view/13694 |